X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with J.B.Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs J.B.CHEMICALS - Comparison Results

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE J.B.CHEMICALS TTK HEALTHCARE/
J.B.CHEMICALS
 
P/E (TTM) x 50.0 15.0 333.6% View Chart
P/BV x 9.2 2.4 388.5% View Chart
Dividend Yield % 0.3 0.2 193.0%  

Financials

 TTK HEALTHCARE   J.B.CHEMICALS
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
J.B.CHEMICALS
Mar-16
TTK HEALTHCARE/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs663318 208.6%   
Low Rs399200 200.0%   
Sales per share (Unadj.) Rs535.6148.0 362.0%  
Earnings per share (Unadj.) Rs15.919.1 83.6%  
Cash flow per share (Unadj.) Rs20.023.9 83.6%  
Dividends per share (Unadj.) Rs4.000.50 800.0%  
Dividend yield (eoy) %0.80.2 389.8%  
Book value per share (Unadj.) Rs137.6128.9 106.7%  
Shares outstanding (eoy) m7.7784.82 9.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.01.7 56.7%   
Avg P/E ratio x33.313.6 245.6%  
P/CF ratio (eoy) x26.510.8 245.4%  
Price / Book Value ratio x3.92.0 192.3%  
Dividend payout %25.12.6 957.4%   
Avg Mkt Cap Rs m4,12721,951 18.8%   
No. of employees `0001.72.7 62.5%   
Total wages/salary Rs m6071,841 32.9%   
Avg. sales/employee Rs Th2,436.74,590.9 53.1%   
Avg. wages/employee Rs Th355.2673.4 52.7%   
Avg. net profit/employee Rs Th72.5592.1 12.3%   
INCOME DATA
Net Sales Rs m4,16212,551 33.2%  
Other income Rs m61542 11.3%   
Total revenues Rs m4,22313,093 32.3%   
Gross profit Rs m1972,055 9.6%  
Depreciation Rs m32412 7.7%   
Interest Rs m3096 31.2%   
Profit before tax Rs m1972,088 9.4%   
Minority Interest Rs m00 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m73469 15.5%   
Profit after tax Rs m1241,619 7.7%  
Gross profit margin %4.716.4 28.9%  
Effective tax rate %37.022.5 164.8%   
Net profit margin %3.012.9 23.1%  
BALANCE SHEET DATA
Current assets Rs m1,6297,778 20.9%   
Current liabilities Rs m1,0584,358 24.3%   
Net working cap to sales %13.727.2 50.3%  
Current ratio x1.51.8 86.3%  
Inventory Days Days3055 54.5%  
Debtors Days Days3480 42.0%  
Net fixed assets Rs m5565,713 9.7%   
Share capital Rs m78170 45.8%   
"Free" reserves Rs m87810,547 8.3%   
Net worth Rs m1,06910,937 9.8%   
Long term debt Rs m1590-   
Total assets Rs m2,39915,574 15.4%  
Interest coverage x7.622.8 33.2%   
Debt to equity ratio x0.10-  
Sales to assets ratio x1.70.8 215.2%   
Return on assets %6.411.0 58.2%  
Return on equity %11.614.8 78.3%  
Return on capital %18.520.0 92.4%  
Exports to sales %0.848.7 1.6%   
Imports to sales %1.47.1 19.8%   
Exports (fob) Rs m336,115 0.5%   
Imports (cif) Rs m58889 6.6%   
Fx inflow Rs m336,169 0.5%   
Fx outflow Rs m631,285 4.9%   
Net fx Rs m-304,884 -0.6%   
CASH FLOW
From Operations Rs m1271,397 9.1%  
From Investments Rs m-146-320 45.6%  
From Financial Activity Rs m22-1,196 -1.8%  
Net Cashflow Rs m3-102 -2.4%  

Share Holding

Indian Promoters % 65.4 55.4 118.1%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 3.7 3.4 109.1%  
FIIs % 5.2 3.9 133.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 37.0 69.7%  
Shareholders   12,723 30,437 41.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   ALKEM LABORATORIES  PLETHICO PHARMA  WOCKHARDT LTD.  TORRENT PHARMA  FRESENIUS KABI ONCO.  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Chart Modest Gains(RoundUp)

Global financial markets ended the holiday shortened week with modest gains. The rally put behind days of decline as concerns regarding swift interest rates hikes were put to ease.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Feb 23, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - ASTRAZENECA PHARMA COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS